The prevalence and clinical significance of inhalant withdrawal symptoms among a national sample.

dc.contributor.author

Perron, Brian E

dc.contributor.author

Glass, Joseph E

dc.contributor.author

Ahmedani, Brian K

dc.contributor.author

Vaughn, Michael G

dc.contributor.author

Roberts, Daniel E

dc.contributor.author

Wu, Li-Tzy

dc.coverage.spatial

New Zealand

dc.date.accessioned

2015-12-03T17:38:32Z

dc.date.issued

2011-04

dc.description.abstract

BACKGROUND: Inhalants are among the most common and dangerous forms of substance use, but very little research on inhalant use disorders exist. Unlike other substances, the Diagnostic and Statistical Manual, 4th edition (DSM-IV) indicates that inhalants do not have an associated withdrawal syndrome among persons who meet criteria for inhalant dependence. METHODS: Using data from the National Epidemiologic Survey on Alcohol and Related Conditions, this study examines the prevalence of withdrawal symptoms among inhalant users. Prevalence of inhalant withdrawal symptoms for inhalants was also compared with the prevalence of cocaine withdrawal symptoms to help determine the presence of an inhalant withdrawal syndrome. RESULTS: Approximately 47.8% of persons who met criteria for inhalant dependence reported experiencing three or more inhalant-related withdrawal symptoms that were clinically significant. Among those with inhalant dependence, almost half of the withdrawal symptoms were as common as the corresponding withdrawal symptoms experienced by persons with cocaine dependence. Furthermore, the percentage of persons with inhalant dependence reporting clinically significant inhalant withdrawal symptoms was almost equal to the percentage of persons with cocaine dependence reporting clinically significant cocaine withdrawal symptoms. CONCLUSIONS: These data provide evidence for an inhalant-related withdrawal syndrome among persons with inhalant dependence. Revisions to DSM-IV should consider including inhalant withdrawal as a diagnostic criterion for this disorder.

dc.identifier

http://www.ncbi.nlm.nih.gov/pubmed/21709745

dc.identifier.uri

https://hdl.handle.net/10161/11014

dc.language

eng

dc.publisher

Informa UK Limited

dc.relation.ispartof

Subst Abuse Rehabil

dc.relation.isversionof

10.2147/SAR.S14937

dc.title

The prevalence and clinical significance of inhalant withdrawal symptoms among a national sample.

dc.type

Journal article

duke.contributor.orcid

Wu, Li-Tzy|0000-0002-5909-2259

pubs.author-url

http://www.ncbi.nlm.nih.gov/pubmed/21709745

pubs.begin-page

69

pubs.end-page

76

pubs.issue

2

pubs.organisational-group

Center for Child and Family Policy

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Duke Institute for Brain Sciences

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Psychiatry & Behavioral Sciences

pubs.organisational-group

Psychiatry & Behavioral Sciences, Social and Community Psychiatry

pubs.organisational-group

Sanford School of Public Policy

pubs.organisational-group

School of Medicine

pubs.organisational-group

University Institutes and Centers

pubs.publication-status

Published

pubs.volume

2011

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
The prevalence and clinical significance of inhalant withdrawal symptoms among a national sample.pdf
Size:
182.84 KB
Format:
Adobe Portable Document Format